Antiplatelet Therapy in Chronic Urticaria

Status Active, not recruiting

Clinical Trial Summary

This study compares the combination of antiplatelets and antihistamine versus antihistamine alone for the treatment of chronic spontaneous urticaria

Clinical Trial Description

This study is a randomized control trial comparing the effectiveness of the combination of antiplatelets and antihistamine and antihistamine alone for the treatment of chronic spontaneous urticaria ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06268470
Study type	Interventional
Source	Chulalongkorn University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	June 1, 2018
Completion date	May 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02435238` - AWARE - Chronic Urticaria	N/A
Not yet recruiting	`NCT05513079` - Positive Psychotherapy-Based Counseling (PPT)	N/A
Terminated	`NCT02047136` - Dietary Treatment for Chronic Urticaria	N/A
Completed	`NCT01803763` - Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients	Phase 2/Phase 3
Terminated	`NCT01170949` - Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria	Phase 2
Completed	`NCT00598611` - Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)	Phase 3
Completed	`NCT01610128` - Development of an Urticaria Control Test	N/A
Completed	`NCT02285049` - Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control Test	N/A
Completed	`NCT02285023` - The Validity, Reliability and Interpretability of Thai-version of Chronic Urticaria Quality of Life Questionnaire
Completed	`NCT01715740` - Study of the Effects of Chinese Herbal Medicine on Chronic Urticaria	Phase 3
Completed	`NCT01960283` - Methotrexate in the Treatment of Chronic Idiopathic Urticaria	Phase 3
Completed	`NCT00481676` - Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria	Phase 2
Completed	`NCT01713725` - Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria	Phase 2
Completed	`NCT01250652` - Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses	Phase 4
Completed	`NCT01111136` - Stress Intervention for Chronic Urticaria	N/A
Recruiting	`NCT01425593` - T Cell Function in Chronic Idiopathic Urticaria	N/A
Completed	`NCT00737451` - Association of Thyroid Autoimmunity and Chronic Urticaria	N/A
Completed	`NCT00628108` - Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months	Phase 3
Completed	`NCT00619801` - Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin	Phase 3
Completed	`NCT01284426` - Natural History of Chronic Urticaria	N/A